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ABSTRACT 
Introduction: In breast cancer (BC), desmoplastic reaction, assembled primarily by fibroblasts, is associated with 
unfavorable prognosis, but the reason of this fact remains still unclear. In this context, nonlinear optics microscopy, 
including Fluorescence Lifetime Imaging Microscopy (FLIM), has provided advancement in cellular metabolism 
research. In this paper, our purpose is to differentiate BC cells metabolism with or without contact to desmoplastic 
reaction. Formalin fixed, paraffin embedded samples were used at different points of hematoxylin stained sections. 
Methodology: Sections from 14 patients with invasive ductal breast carcinoma were analyzed with FLIM methodology 
to NAD(P)H and FAD fluorescence lifetime on a Confocal Upright LSM780 NLO device (Carl Zeiss AG, Germany). 
Quantification of the fluorescence lifetime and fluorescence intensity was evaluated by SPC Image software (Becker 
&Hickl) and ImageJ (NIH), respectively. Optical redox ratio was calculated by dividing the FAD fluorescence intensity 
by NAD(P)H fluorescence intensity. Data value for FLIM measurements and fluorescence intensities were calculated 
using Wilcoxon test; p< 0.05 was considered significant. Results: BC cells in contact with desmoplastic reaction 
presented a significantly lower NAD(P)H and FAD fluorescence lifetime. Furthermore, optical redox ratio was also 
lower in these tumor cells. Conclusion: Our results suggest that contact of BC cells with desmoplastic reaction increase 
their metabolic activity, which might explain the adverse prognosis of cases associated with higher peritumoral 
desmoplastic reaction. 
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 1. INTRODUCTION 
 It is known that the extracellular matrix (ECM) can modulate cancer behavior, influencing tumor growth, 
differentiation and invasion, thus potentially conferring prognostic and predictive information1. In breast cancers (BC), 
there is a scirrhous or desmoplastic reaction caused by interactions between tumor and stromal cells, mainly fibroblasts2. 
In fact, theses fibroblasts can activate BC development and progression through the release of bioactive molecules, like 
chemokines and growth factors. In addition, these molecules contribute to ECM alterations and remodeling, 
characteristic of this neoplasm3,4. Further, desmoplastic reaction is an important independent recurrence risk marker for 
breast cancer, and its presence is linked with infiltrative and stellate pattern, concluding that an intense desmoplastic 
reaction is associated to a poor prognosis5,6. However, metabolic alterations related to desmoplastic reaction in BC cells 
have not yet been elucidated, especially in human BC. 
 Tumor cells have increased cell metabolism when compared to normal cells, due to their rapid proliferation7. 
This fact is linked with change in the distribution and the relative concentrations of metabolic coenzymes, NAD(P)H and 
FAD8-10. Further, NAD(P)H and FAD are autofluorescence, but they differ with distinct maxima excitation and emission 
wavelength, so it is possible to isolate each one with optical techniques11. The most common method for evaluating cell 
metabolism is the “optical redox ratio” (ratio between NAD(P)H and FAD fluorescence intensity)12,13, wherein, low 
values usually indicate increased metabolic activity13. 
 Fluorescence Lifetime Imaging Microscopy (FLIM) is a nonlinear microscopic technique capable of measuring 
NAD(P)H and FAD lifetime fluorescence12. Changes in these lifetime values reflect cell microenvironment alterations, 
like oxygen, tyrosine and tryptophan concentrations, temperature, and pH12,14, in summary, cellular metabolism, both in 
vivo and on routinely fixed samples11,15. Studies performed with paraffin fixed and unfixed mouse tissue specimens 
recognized that the fixation process did not significantly impact in the reliability of NAD(P)H and FAD 
measurements11,15. Other reports have also demonstrated that the chemical environment around the fluorophores is 
somehow preserved after routine histological sample processing16. As the fixation and embedding process of tissue 
samples in our institution is similar to the one described by these authors, it is reasonable to assume that we may 
compare metabolic states in different specimens even after the fixation procedure. Using this approach, our purpose was 
to differentiate tumor cell metabolism with or without contact to desmoplastic reaction, in patients with BC, using 
formalin fixed, paraffin embedded samples, at different points of hematoxylin stained sections. 
2. MATERIALS AND METHODS 
2.1. Patients and tissues 
 This is a retrospective study, using formalin fixed paraffin embedded (FFPE) archival tissue specimens from the 
Department of Pathology of the Faculty of Medical Sciences – State University of Campinas (UNICAMP, São Paulo, 
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 Brazil). Breast cancer specimens were selected from consecutive 14 female patients, who were submitted to primary 
mastectomy or quadrantectomy. None of these patients had received previous chemotherapy/radiotherapy, nor had they 
history of other types of cancer. The Research Ethics Committee of the Faculty of Medical Sciences – UNICAMP 
approved this study (CEP #087/2008). 
 Four µm sections stained with hematoxylin and eosin staining were reviewed to assess pathological 
characteristics and to select regions of interest (ROIs), based on: (1) BC cells with desmoplastic reaction (WD), and (2) 
BC cells without desmoplastic reaction (WoD) (Figure 1). The ROIs were transported to the consecutive hematoxylin 
stained sections to observe fluorescence lifetime and intensity. 
2.2. Experimental setup 
 We used a 40x/1.3 NA oil immersion EC Plan-Neofluar objective on a Confocal Upright LSM780 NLO device 
(Carl Zeiss AG, Germany) equipped with a Becker & Hickl TCSPC FLIM system. FLIM was excited with a 405 nm 
diode laser (BDL-405-SMC, Becker & Hickl, Berlin, Germany) with 65 ps pulses and 80 MHz repetition rate. A filter 
cube with a longpass LP495 nm at 45° splitted the beams in two, one arm with a bandpass BP445±45 nm to capture the 
NAD(P)H signal and the other with a bandpass BP535±22 nm to capture the FAD signal. Each region with 177 x 177 
µm2 (256 x 256 pixels) was excited for 120s at a rate of approximately 1x105ph/s and detected with the Becker & Hickl 
PMH-100 detector. The photon count rate did not change during the acquisition process, ensuring that photobleaching 
did not occur (Figure 2). 
2.3. Image and statistical analysis 
 In all 56 images (four images of each case: NAD(P)H autofluorescence, FAD autofluorescence, NAD(P)H-
fluorescence lifetime, and FAD- fluorescence lifetime) BC cells were delimited. The fluorescence intensity was 
determined using the ImageJ software (NIH, USA). “Optical redox ratio” was performed dividing the quantity of FAD 
fluorescence intensity by the quantity of NAD(P)H fluorescence intensity (1)12. 
Optical  redox  ratio =    FAD  integrated  densityNAD P H  integrated  density                             (1) 
 The SPC Image software (Becker & Hickl) was used to analyze the fluorescence lifetime of each metabolic 
molecules (NAD(P)H and FAD), as described previously by our group17, with applied binning of 5 x 5. Data are 
expressed by median values and interquartile range. We compared fluorescence lifetime and “optical redox ratio” 
measurements using Wilcoxon tests; p< 0.05 was considered significant. Statistical analysis was performed using Prism 
5.0 (GraphPad Software, La Jolla, CA, USA). 
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Figure 1: Images A to D feature the histological findings from two distinct patients. Images A and C represent breast cancer (BC) 
cells with desmoplasia, while images B and D represent BC cells without desmoplasia. Hematoxylin and eosin stained slices (400x). 
          
          
Figure 2: A: fluorescence intensity; B: FLIM image. From left to right: (1) NAD(P)H in breast cancer (BC) cells with desmoplasia 
(WD); (2) FAD in BC cells WD; (3) NAD(P)H in BC cells without desmoplasia (WoD), and (4) FAD in BC cells WoD. 
3. RESULTS 
 In all 14 patients there were ROIs with BC cells WD and WoD. Further, the fluorescence intensity and lifetime 
was feasible in all demarcated regions in the hematoxylin stained slices. Figure 3 shows that BC cells WD had faster 
NAD(P)H lifetime fluorescence, 293.0 ps (172.7 – 382.4), compared to BC cells WoD, 382.9 ps (370.4 – 154.2)          
(p= 0.04). FAD lifetime was faster in BC cells WD, 299.0 ps (171.2 – 428.4), when compared to BC cells WoD, 343.5 
(236.9 – 535.9) (p= 0.04). 
A1 A2 A3 A4 
B1 B2 B3 B4 
A B C D 
Proc. of SPIE-OSA Vol. 9536  95360L-4
  
Figure 3: Comparison between BC cells WD and WoD for: (A) NAD(P)H fluorescence lifetime; and (B) FAD fluorescence lifetime. 
Wilcoxon test was applied with significant p less than 0.05. 
 Further, Figure 4 shows that BC cells WD had a decrease of the “optical redox ratio”, 1.29 (1.00 – 2.32), as 
compared to BC cells WoD, 1.89 (1.39 – 2.92) (p= 0.01). 
 
Figure 4: Comparison between “optical redox ratio” in BC cells WD and WoD. Wilcoxon test was applied with significant p less than 
0.05. 
4. Discussion  
 In this preliminary study, our results showed that the use of FLIM is feasible in hematoxylin stained sections 
from routinely FFPE breast cancer samples, obtained from the archives of the Pathology Laboratory. Further, on the 
same section we observed different fluorescence lifetime patterns, depending on the ROI. The statistical analyzes 
revealed that BC cells WD had a NAD(P)H and FAD fluorescence lifetime faster than the BC cells WoD. Further, 
metabolism was higher in the former than in the latter. 
 In vitro study demonstrated that NAD(P)H has a lower average fluorescence lifetime in highly metastatic 
variant of cancer cells, when compared to the low metastatic variant, both in rat or human linages18. Further, in 
pancreatic cancer animal model the results were similar, that is, histological high grade pancreatic cancer was associated 
with a reduction in average fluorescence lifetime in both bound and free NAD(P)H. However, no association was found 
for the FAD average fluorescence lifetime12. In this context, desmoplastic reaction could influence an infiltrative tumor 
pattern5,6 by enhancing proliferation and spread of BC cells, as result of increased metabolic activity. Therefore, our 
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 finding that BC cells WD are more metabolically active due to lower NAD(P)H and FAD fluorescence lifetime is 
supported by previous data. Further, “optical redox ratio” reinforced lower average fluorescence lifetime found in our 
samples, since the low value of this ratio indicates an increase in metabolic activity. 
 Despite the evidences presented herein of more aggressive behavior of BC cells in contact with desmoplastic 
reaction, the limited number of cases did not allow survival analyzes necessary to demonstrate the clinical implications 
of these findings (e.g., recurrence rate, progression-free survival and global survival). To specifically address the clinical 
value of these findings, studies with larger number of patients is needed. 
 In summary, our results using FLIM applied on routinely processed BC sections support the assumption that the 
non cellular stromal component, as the desmoplastic reaction, could influence cancer cell metabolism, inducing higher 
activity, and, consequently, more infiltrative and metastatic potential. Recognition of such mechanisms could be the 
basis of novel therapeutic approaches in the future.  
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